1. Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties

   • C. P. Winlove
   • K. H. Parker
   • A. J. Bailey

   Originals 01 October 1996 Pages: 1131 - 1139

2. Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance

   • R. Brandt
   • C. Landmesser
   • D. Michaelis

   Originals 01 October 1996 Pages: 1140 - 1147

3. Hypoglycaemic effect of AICAriboside in mice

   • M. F. Vincent
   • M. D. Erion
   • G. Van den Berghe

   Originals 01 October 1996 Pages: 1148 - 1155

4. Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects

   • M. Trovati
   • P. Massucco
   • G. Anfossi

   Originals 01 October 1996 Pages: 1156 - 1164

5. Dual function of the intron of the rat insulin I gene in regulation of gene expression

   • A. Damert
   • B. Leibiger
   • I. B. Leibiger

   Originals 01 October 1996 Pages: 1165 - 1172

6. Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein

   • M. Veiga-da-Cunha
   • L. Z. Xu
   • E. Van Schaftingen

   Originals 01 October 1996 Pages: 1173 - 1179

7. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM

   • J. R. Zierath
   • L. He
   • H. Wallberg-Henriksson

   Originals 01 October 1996 Pages: 1180 - 1189

8. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity

   • L. Frittitta
   • J. Youngren
   • I. D. Goldfine

   Originals 01 October 1996 Pages: 1190 - 1195

9. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243

   • T. Kobayashi
   • Y. Oka
   • Å. Lernmark

   Originals 01 October 1996 Pages: 1196 - 1200

10. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance

    • S. M. Haffner
    • H. Miettinen
    • M. P. Stern

    Originals 01 October 1996 Pages: 1201 - 1207

11. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects

    • D. Worm
    • J. Vinten
    • H. Beck-Nielsen

    Originals 01 October 1996 Pages: 1208 - 1214

12. Mast cells and type VIII collagen in human diabetic nephropathy

    • B. M. Rüger
    • Q. Hasan
    • T. J. Neale

    Originals 01 October 1996 Pages: 1215 - 1222

13. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM

    • S. Genovese
    • R. Bonfanti
    • E. Bonifacio

    Originals 01 October 1996 Pages: 1223 - 1226

14. GLP-1 does not acutely affect insulin sensitivity in healthy man

    • L. Ørskov
    • J. J. Holst
    • O. Schmitz

    Originals 01 October 1996 Pages: 1227 - 1232

15. Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in white caucasian subjects or evidence of abnormal function when expressed in vitro

    • H. Sakura
    • N. Wat
    • F. M. Ashcroft

    Rapid Communication 01 October 1996 Pages: 1233 - 1236

16. Autoantibodies to IA-2 not detected in NOD mice or BB rats

    • M. G. DeSilva
    • H. S. Jun
    • M. S. Lan

    Letter To The Editors 01 October 1996 Pages: 1237 - 1238

17. Mortality of childhood-onset IDDM patients in Estonia

    • T. Podar
    • A. Solntsev
    • R. E. LaPorte

    Letter To The Editors 01 October 1996 Pages: 1238 - 1239

18. Abnormal protein redox status in the lens and vitreous of diabetic subjects

    • G. Vendemiale
    • I. Grattagliano
    • E. Altomare

    Letter To The Editors 01 October 1996 Pages: 1239 - 1240

19. Glucagon-like peptide-1(7–36) amide and glycogen synthesis in the liver

    • Y. Nakagawa
    • K. Kawai
    • K. Yamashita

    Letter To The Editors 01 October 1996 Pages: 1241 - 1242

20. Diabetes mellitus and Alzheimer’s disease

    • F. Lithner

    Letter To The Editors 01 October 1996 Pages: 1242 - 1242

21. Elevated circulating adhesion molecules in NIDDM — potential mediators in diabetic macroangiopathy

    • P. Fasching
    • W. Waldhäusl
    • O. F. Wagner

    Letter To The Editors 01 October 1996 Pages: 1242 - 1244

22. Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL

    • L. Cominacini
    • U. Garbin
    • V. Lo Cascio

    Letter To The Editors 01 October 1996 Pages: 1244 - 1244

23. Erratum to: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients

    • S. Kumar
    • A. J. M. Boulton
    • the Troglitazone study group

    Erratum 01 October 1996 Pages: 1245 - 1245